ARTICLE | Company News
Endo sales and marketing update
February 29, 2016 8:00 AM UTC
Endo launched Belbuca buprenorphine in the U.S. to manage pain severe enough to require daily, around-the-clock, long-term opioid treatment for which alternative treatment options are inadequate. The...